Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China flag China · Delayed Price · Currency is CNY
17.65
+1.43 (8.82%)
Mar 10, 2026, 2:55 PM CST
78.64%
Market Cap 6.83B
Revenue (ttm) 720.67M
Net Income (ttm) -19.73M
Shares Out 420.78M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE 115.86
Dividend n/a
Ex-Dividend Date n/a
Volume 13,267,621
Average Volume 7,350,319
Open 16.36
Previous Close 16.22
Day's Range 16.33 - 17.80
52-Week Range 9.00 - 22.55
Beta 0.49
RSI 50.80
Earnings Date Mar 31, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 683
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688488
Full Company Profile

Financial Performance

In 2025, SHA:688488's revenue was 720.67 million, an increase of 72.49% compared to the previous year's 417.80 million. Losses were -19.73 million, -86.02% less than in 2024.

Financial Statements

News

There is no news available yet.